Your browser doesn't support javascript.
loading
Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.
Yan, Ningning; Zhang, Ziheng; Guo, Sanxing; Shen, Shujing; Li, Xingya.
  • Yan N; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang Z; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Guo S; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Shen S; Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li X; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Med (Lausanne) ; 10: 1130012, 2023.
Article en En | MEDLINE | ID: mdl-37293311
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article